me 2303 has been researched along with 7-o-(2,6-dideoxy-2-fluorotalopyranose)adriamycinone in 1 studies
Studies (me 2303) | Trials (me 2303) | Recent Studies (post-2010) (me 2303) | Studies (7-o-(2,6-dideoxy-2-fluorotalopyranose)adriamycinone) | Trials (7-o-(2,6-dideoxy-2-fluorotalopyranose)adriamycinone) | Recent Studies (post-2010) (7-o-(2,6-dideoxy-2-fluorotalopyranose)adriamycinone) |
---|---|---|---|---|---|
23 | 1 | 0 | 7 | 0 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukatsu, S; Komuro, K; Kunimoto, S; Nosaka, C; Takeuchi, T; Tsuchiya, T | 1 |
1 other study(ies) available for me 2303 and 7-o-(2,6-dideoxy-2-fluorotalopyranose)adriamycinone
Article | Year |
---|---|
Biological activities of new anthracyclines containing fluorine, FAD104 and its metabolites.
Topics: Animals; DNA; Doxorubicin; Esterases; Female; Fluorine; Humans; Hydrolysis; Leukemia L1210; Leukemia P388; Lymphoma, Non-Hodgkin; Mice; Molecular Structure; RNA; Tumor Cells, Cultured | 1990 |